Kathy Lang, PhD

Perspectives

COVID-19 Pandemic Vindicates the ISPOR Value Flower

06/17/2020

Jason Shafrin, PhD

Kathy Lang, PhD

Ross Maclean, MD

Abstract: What is the right price for a new treatment for COVID-19? One common approach—which is frequently used worldwide and in the United States by the Institute of Clinical and Economic Review—measures treatment...

...

06/17/2020

Journal of Clinical Pathways

Pharma Insights

Real-World Data Will Continue to Provide Real Value to the Drug Development and Commercialization Process

05/19/2020

Sajjad Raza, MD, PhD, MSM

Kathy Lang, PhD

Randomized controlled trials provide critically needed evidence of drugs’ safety and efficacy, yet their results are not always generalizable to diverse populations in less idealized settings. Thus, we need data...

...

05/19/2020

Journal of Clinical Pathways